Open access · OA
via OpenAlex
Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway
Aslam Ali Khan, Dru S. Dace, Alexey G. Ryazanov, Jennifer Kelly, Rajendra S. Apte
American Journal Of Pathology · 2010 · ▲ 58 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2353/ajpath.2010.090836
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Khan, A.A., Dace, D.S., Ryazanov, A.G., Kelly, J., & Apte, R.S. (2010). Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway. <em>American Journal Of Pathology</em>. https://doi.org/10.2353/ajpath.2010.090836
Vancouver
Khan AA, Dace DS, Ryazanov AG, Kelly J, Apte RS. Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway. American Journal Of Pathology. 2010. doi:10.2353/ajpath.2010.090836.
BibTeX
@article{aslam2010Resver,
title = {Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway},
author = {Aslam Ali Khan and Dru S. Dace and Alexey G. Ryazanov and Jennifer Kelly and Rajendra S. Apte},
journal = {American Journal Of Pathology},
year = {2010},
doi = {10.2353/ajpath.2010.090836},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Seminars in Cell and Developmental Biology 2021
Preprint · OA
Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis
Expert Opinion on Pharmacotherapy 2021
Preprint · OA
Development of the PARP inhibitor talazoparib for the treatment of advanced<i>BRCA1</i>and<i>BRCA2</i>mutated breast cancer
Nature 2019
Open access · OA
A view on drug resistance in cancer
Elsevier eBooks 2013
Citation only
Stress Response, Inflammaging, and Cancer
Rheumatic Disease Clinics of North America 2000
Citation only
OSTEOPOROSIS
Endocrinology and Metabolism Clinics of North America 2023
Open access · OA